156 related articles for article (PubMed ID: 18582432)
1. Impact of short- and medium-chain organic acids, acylcarnitines, and acyl-CoAs on mitochondrial energy metabolism.
Sauer SW; Okun JG; Hoffmann GF; Koelker S; Morath MA
Biochim Biophys Acta; 2008 Oct; 1777(10):1276-82. PubMed ID: 18582432
[TBL] [Abstract][Full Text] [Related]
2. Substrate specificity of human carnitine acetyltransferase: Implications for fatty acid and branched-chain amino acid metabolism.
Violante S; Ijlst L; Ruiter J; Koster J; van Lenthe H; Duran M; de Almeida IT; Wanders RJ; Houten SM; Ventura FV
Biochim Biophys Acta; 2013 Jun; 1832(6):773-9. PubMed ID: 23485643
[TBL] [Abstract][Full Text] [Related]
3. Carnitine palmitoyltransferase 2: New insights on the substrate specificity and implications for acylcarnitine profiling.
Violante S; Ijlst L; van Lenthe H; de Almeida IT; Wanders RJ; Ventura FV
Biochim Biophys Acta; 2010 Sep; 1802(9):728-32. PubMed ID: 20538056
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-coA dehydrogenase deficiency.
Roe CR; Millington DS; Maltby DA; Bohan TP; Kahler SG; Chalmers RA
Pediatr Res; 1985 May; 19(5):459-66. PubMed ID: 4000772
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of acyl-CoA and acylcarnitine esters accumulated during abnormal mitochondrial fatty acid oxidation.
Kler RS; Jackson S; Bartlett K; Bindoff LA; Eaton S; Pourfarzam M; Frerman FE; Goodman SI; Watmough NJ; Turnbull DM
J Biol Chem; 1991 Dec; 266(34):22932-8. PubMed ID: 1744086
[TBL] [Abstract][Full Text] [Related]
6. Relationship between unusual hepatic acyl coenzyme A profiles and the pathogenesis of Reye syndrome.
Corkey BE; Hale DE; Glennon MC; Kelley RI; Coates PM; Kilpatrick L; Stanley CA
J Clin Invest; 1988 Sep; 82(3):782-8. PubMed ID: 3417871
[TBL] [Abstract][Full Text] [Related]
7. Renal handling of carnitine in secondary carnitine deficiency disorders.
Stanley CA; Berry GT; Bennett MJ; Willi SM; Treem WR; Hale DE
Pediatr Res; 1993 Jul; 34(1):89-97. PubMed ID: 8356025
[TBL] [Abstract][Full Text] [Related]
8. Measurement of tissue acyl-CoAs using flow-injection tandem mass spectrometry: acyl-CoA profiles in short-chain fatty acid oxidation defects.
Palladino AA; Chen J; Kallish S; Stanley CA; Bennett MJ
Mol Genet Metab; 2012 Dec; 107(4):679-83. PubMed ID: 23117082
[TBL] [Abstract][Full Text] [Related]
9. The role of carnitine in intracellular metabolism.
Bremer J
J Clin Chem Clin Biochem; 1990 May; 28(5):297-301. PubMed ID: 2199593
[TBL] [Abstract][Full Text] [Related]
10. Effect of salicylic acid and diclofenac on the medium-chain and long-chain acyl-CoA formation in the liver and brain of mouse.
Kasuya F; Kazumi M; Tatsuki T; Suzuki R
J Appl Toxicol; 2009 Jul; 29(5):435-45. PubMed ID: 19391105
[TBL] [Abstract][Full Text] [Related]
11. Quantification of Free Carnitine and Acylcarnitines in Plasma or Serum Using HPLC/MS/MS.
Scott D; Heese B; Garg U
Methods Mol Biol; 2016; 1378():11-9. PubMed ID: 26602112
[TBL] [Abstract][Full Text] [Related]
12. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system.
Reddy JK; Hashimoto T
Annu Rev Nutr; 2001; 21():193-230. PubMed ID: 11375435
[TBL] [Abstract][Full Text] [Related]
13. Cofactors and metabolites as potential stabilizers of mitochondrial acyl-CoA dehydrogenases.
Lucas TG; Henriques BJ; Rodrigues JV; Bross P; Gregersen N; Gomes CM
Biochim Biophys Acta; 2011 Dec; 1812(12):1658-63. PubMed ID: 21968293
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibitory effect of long-chain acyl-CoA esters on succinate and glutamate transport into rat liver mitochondria and its possible implications for long-chain fatty acid oxidation defects.
Ventura FV; Ruiter J; Ijlst L; de Almeida IT; Wanders RJ
Mol Genet Metab; 2005 Nov; 86(3):344-52. PubMed ID: 16176879
[TBL] [Abstract][Full Text] [Related]
15. Catalytic defect of medium-chain acyl-coenzyme A dehydrogenase deficiency. Lack of both cofactor responsiveness and biochemical heterogeneity in eight patients.
Amendt BA; Rhead WJ
J Clin Invest; 1985 Sep; 76(3):963-9. PubMed ID: 3840178
[TBL] [Abstract][Full Text] [Related]
16. C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects.
Gregersen N; Wintzensen H; Christensen SK; Christensen MF; Brandt NJ; Rasmussen K
Pediatr Res; 1982 Oct; 16(10):861-8. PubMed ID: 7145508
[TBL] [Abstract][Full Text] [Related]
17. Tandem Mass Spectrometry for the Analysis of Plasma/Serum Acylcarnitines for the Diagnosis of Certain Organic Acidurias and Fatty Acid Oxidation Disorders.
Scott D; Clinton Frazee C; Heese B; Garg U
Methods Mol Biol; 2022; 2546():27-34. PubMed ID: 36127575
[TBL] [Abstract][Full Text] [Related]
18. Carnitine deficiency, organic acidemias, and Reye's syndrome.
Stumpf DA; Parker WD; Angelini C
Neurology; 1985 Jul; 35(7):1041-5. PubMed ID: 3892364
[TBL] [Abstract][Full Text] [Related]
19. Carnitine palmitoyltransferase 2 and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines.
Violante S; Ijlst L; Te Brinke H; Tavares de Almeida I; Wanders RJ; Ventura FV; Houten SM
FASEB J; 2013 May; 27(5):2039-44. PubMed ID: 23322164
[TBL] [Abstract][Full Text] [Related]
20. Developmental regulation and localization of carnitine palmitoyltransferases (CPTs) in rat brain.
Jernberg JN; Bowman CE; Wolfgang MJ; Scafidi S
J Neurochem; 2017 Aug; 142(3):407-419. PubMed ID: 28512781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
